MAP kinases-Regulated Proteins in Downstream Signaling Pathways of Vasopressin V2 Receptor in Kidney Collecting Duct

被引：0
|
作者：
Jang, Hyo-Ju [1 ]
Jung, Hyun [1 ]
Choi, Hyo-Jung [1 ]
Park, Eui-Jung [1 ]
Park, Hye-Jeong [1 ]
Kwon, Tae-Hwan [1 ]
机构：
[1] Kyungpook Natl Univ, Sch Med, Daegu, South Korea
来源：
FASEB JOURNAL | 2020年 / 34卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
10.1096/fasebj.2020.34.s1.03844
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis
    Tian, Y
    Sandberg, K
    Murase, T
    Baker, EA
    Speth, RC
    Verbalis, JG
    ENDOCRINOLOGY, 2000, 141 (01) : 307 - 314
  • [42] Intracellularly retained V2 vasopressin receptor mutants activate different UPR signalling pathways.
    Lautz, K.
    Grantcharova, E.
    Schwieger, I.
    Rosenthal, W.
    Wiesner, B.
    Huebner, N.
    Hermosilla, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 17 - 18
  • [43] Characterization of a functional V1B vasopressin receptor in the male rat kidne evidence for cross talk between V1B and V2 receptor signaling pathways
    Hus-Citharel, Annette
    Bouby, Nadine
    Corbani, Maithe
    Mion, Julie
    Mendre, Christiane
    Darusi, Judit
    Tomboly, Csaba
    Trueba, Miguel
    Serradeil-Le Gal, Claudine
    Llorens-Cortes, Catherine
    Guillon, Gilles
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 321 (03) : F305 - F321
  • [44] Vasopressin V2 receptor antagonists in autosomal dominant polycystic kidney disease: efficacy, safety, and tolerability
    Meijer, Esther
    Gansevoort, Ron T.
    KIDNEY INTERNATIONAL, 2020, 98 (02) : 289 - 293
  • [45] Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease
    Cao, Xudong
    Wang, Peng
    Yuan, Haoxing
    Zhang, Haoran
    He, Yan
    Fu, Kequan
    Fang, Qian
    Liu, Hongli
    Su, Limin
    Yin, Long
    Xu, Pei
    Xie, Yuyang
    Xiong, Xiaochun
    Wang, Junqi
    Zhu, Xu
    Guo, Dong
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 9295 - 9311
  • [46] Michaelis-Menten Quantification of Ligand Signaling Bias Applied to the Promiscuous Vasopressin V2 Receptor
    Heydenreich, Franziska Marie
    Plouffe, Bianca
    Rizk, Aurelien
    Milic, Dalibor
    Zhou, Joris
    Breton, Billy
    Le Gouill, Christian
    Inoue, Asuka
    Bouvier, Michel
    Veprintsev, Dmitry B.
    MOLECULAR PHARMACOLOGY, 2022, 102 (03) : 139 - 149
  • [47] Restoration of peripheral V2 receptor vasopressin signaling fails to correct behavioral changes in Brattleboro rats
    Balazsfi, Diana
    Pinter, Otto
    Klausz, Barbara
    Kovacs, Krisztina B.
    Fodor, Anna
    Torok, Bibiana
    Engelmann, Mario
    Zelena, Dora
    PSYCHONEUROENDOCRINOLOGY, 2015, 51 : 11 - 23
  • [48] Extracellular signal-regulated kinases1/2 signaling pathways are not involved in endothelin regulation of mouse inner medullary collecting duct nitric oxide production
    Hyndman, Kelly A.
    MacDonell, Alexander H.
    Pollock, Jennifer S.
    LIFE SCIENCES, 2012, 91 (13-14) : 578 - 582
  • [49] Sustained stimulation of vasopressin V2 receptors in rats strongly enhances the capacity of the cortical collecting duct (CCD) to reabsorb sodium and water
    Bankir, L
    Nicco, C
    Wittner, M
    DiStefano, A
    Pajaud, S
    Bouby, N
    FASEB JOURNAL, 2000, 14 (04): : A347 - A347
  • [50] FOXO transcription factors are negatively regulated by p38 map kinases downstream of FLT3 receptor signaling.
    Scheijen, B
    Ngo, HT
    Griffin, JD
    BLOOD, 2005, 106 (11) : 63A - 63A
12345